Fig. 3From: STMN1 as a novel prognostic biomarker in HCC correlating with immune infiltrates and methylationROC analysis of STMN1 and nomogram model. A ROC curve for diagnosis to distinguish tumor from normal tissue. B ROC curve analysis of time-dependent survival to predict 1-, 3-, and 5-year survival. C A nomogram model combining clinicopathological factors and STMN1 expression levels to predict 1-year, 3-year, and 5-year survivalBack to article page